Statement from the Heads of HTA Agency on the Pharmaceutical Legislation

At their meeting at the end of January 2024 the Heads of HTA Agencies issued a statement highlighting areas of particular interest for HTA in the revised Pharmaceutical Legislation for the European Union. See full statement here